Financial Statements

Organon & Co. (OGN)


-0.38 (-1.25%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019
Retained Earnings (Previous Year) -219--
Net Income 1,3512,1603,218
Stock Dividends -1,985-2,379-3,218
Dividend Paid -145--
Retained Earnings -998-219-

PPE Schedule

Year 2021 2020 2019
Gross PPE 984680-
Annual Depreciation 477582789
Capital Expenditure -488-278-109
Net PPE 973984680

Intangible and Goodwill Schedule

Year 2021 2020 2019
Intangible and Goodwill (Previous Year) -4,6034,603
New Purchases ---
Intangible and Goodwill 4,6034,6034,603

Organon & Co. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Organon & Co. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.